Business
Bionik to Present at the 9th World Congress for Neurorehabilitation
Bionik to Present at the 9th World Congress for Neurorehabilitation.
About this update from Bionik Laboratories Corp.
[{"type":"text","content":"\n\n TORONTO and BOSTON, May 04, 2016 (GLOBE NEWSWIRE) -- Bionik Laboratories Corp. (OTCQX:BNKL), a global pioneering robotics company focused on providing rehabilitation solutions to individuals with neurological disorders (“Bionik” or the \"Company\"), announced today that Hermano I. Krebs, Ph.D., M.S., its Chief Science Officer, will present at the following events during the 9th World Congress for Neurorehabilitation being held in Philadelphia, PA from May 10 – 13, 2016.\n Event: Parallel Symposia – Rehabilitation Robotics: Lower ExtremityDate: May 11, 2016 at 4:00 p.m. ETTopic: Robotic Assistive Steppers for Locomotor Training: Trotting Back to the Starting Gate Event: Evaluation of New Rehabilitation Technologies ForumDate: May 12, 2016 at 4:00 p.m. ETTopic: Evaluating Neurotechnologies: A World of Challenges and Opportunities About 9th World Congress for Neuro RehabilitationThe 9th World Congress, guided by the theme \"From Science to Society for NeuroRehabilitation,” will cover both inspiring innovations in neurorehabilitation and their societal impacts in Philadelphia, May 10 - 13, 2016. WCNR 2016 is for all professionals involved in the multidisciplinary approach to neurorehabilitation: physicians, physical and occupational therapists, psychologists, speech therapists, rehabilitation engineers, basic neuroscientists and others. The congress will take interdisciplinary networking a step further, with symposia bridging neurorehabilitation, neurology, neurosurgery and related disciplines. About Bionik LaboratoriesBionik Laboratories (OTCQX:BNKL), is a global, pioneering robotics company focused on providing rehabilitation solutions to individuals with neurological disorders. Through the acquisition of Interactive Motion Technologies, Bionik has added a portfolio of products focused on upper and lower extremity rehabilitation of stroke patients. The Company now has three products on the market and three products in varying stages of development. The InMotion Systems - the InMotion ARM™, InMotion WRIST™, InMotion ARM/HAND™ and InMotion ANKLE™, are designed to provide intelligent, patient-adaptive therapy in a manner that has been clinically verified to maximize neuro-recovery. Bionik is also developing a lower-body exoskeleton, ARKE™, designed to allow paraplegics ...